Additionally, quercetin’s protective effect on inflammation-dependent cancer was evident in its suppression of COX-2 in breast cancer cells via its attenuation of p300/HAT-mediated signaling (190) (Table 1 and Figure 3). This evidence concerns the gene EP300 and breast cancer.